ImmunoCellular amends follow-on

ImmunoCellular Therapeutics Ltd. (NYSE-M:IMUC), Calabasas, Calif.
Business: Cancer
Date

Read the full 92 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE